Recent Updates
Recently added Catalysts
HCTI Positive Sentiment Score: 75/100

Healthcare Triangle, Inc. Signs Advance Agreement for the Acquisition of Next-Generation AI Customer Engagement Business, on track to generate $34M in Revenue for FY 2025

Key Takeaway: Healthcare Triangle, Inc. has signed an Advance Agreement to acquire Teyame AI LLC, an AI customer engagement business. This strategic acquisition is projected to generate approximately $34 million in revenue for FY 2025 and elevate HCTI's position in the AI-powered customer engagement sector. The total consideration for the deal is anticipated to be around $50 million, contingent upon customary closing conditions and shareholder approval. The integration aims to enhance patient engagement and create a next-generation ecosystem influential in the healthcare industry.

Market Sentiment Analysis

POSITIVE FACTORS

  • The acquisition is expected to generate approximately $34 million in incremental annual revenue for FY 2025.
  • HCTI is positioned to enhance its financial performance significantly through this acquisition.
  • The integration of AI-powered engagement platforms is likely to create an intelligent ecosystem for healthcare.

CONCERNS & RISKS

  • The acquisition is subject to negotiation, due diligence, and shareholder approval, which may lead to delays.
  • There are inherent risks associated with the forward-looking statements regarding revenue projections.

Full Press Release Details

Healthcare Triangle, Inc. Signs Advance Agreement
for the Acquisition of Next-Generation AI Customer
Engagement Business, on track to generate $34M in Revenue for FY 2025
PLEASANTON, Calif., December 10, 2025 (PR NEWSWIRE)
- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions
for healthcare and life sciences, today announces that it has entered into an Advance Agreement with Teyame AI LLC, a St Kitts and Nevis
corporation ("Teyame"), as part of its planned acquisition of the shares of Teyame 360 SL and Datono Mediacion SL, companies
incorporated in Spain ("Assets"), which are run together as a Spain-based leader in AI-powered omnichannel customer experience
(CX) solutions. This acquisition would position the Company as a global force in AI-powered customer and patient engagement.
The proposed transaction contemplates up to approximately
$50 million of total consideration, consisting of a combination of cash, shares of the Company's common stock, shares of non-voting
convertible preferred stock, and contingent earnout-based equity consideration, subject to the final terms of a definitive purchase agreement.
The parties currently anticipate targeting a closing in the first quarter of 2026, subject to the negotiation and execution of a definitive
purchase agreement, completion of due diligence, required shareholder approval, and other customary closing conditions. This communication
does not constitute a solicitation of any proxy, vote or approval.
Based on financial information the Company has
received from Teyame, the Company expects the Assets to generate approximately $34 million in incremental annual revenue and $4.2 million
in incremental EBITDA for fiscal year 2025. The planned acquisition represents a pivotal moment in HCTI's evolution from healthcare IT
provider to comprehensive digital health innovator and is expected to significantly enhance HCTI's financial performance and shareholder
"The transaction will bring real world
lived experience of Agentic Gen AI and is about to change the game for HCTI. It's where the rubber meets the road in AI" added
David Ayanoglou, Chief Financial Officer of HCTI.
We are pleased to take this decisive
step with the signing of the binding advance agreement. Integrating these AI-powered engagement platforms with HCTI's healthcare
technologies positions us to deliver a next-generation, intelligent ecosystem for patients, providers, and global markets."-
Sujatha Ramesh, Chief Operating Officer, Principal Executive Officer, and Director, Board of Directors, HCTI.
acquisition is slated to be a critical step in HCTI's broader strategy focused on:
This strategic acquisition will combine HCTI's
deep healthcare technology expertise with the acquired Assets' AI automation customer engagement platform(s), so that an integrated
ecosystem can be created where every patient touchpoint would become intelligent, personalized, and outcome focused.
About Healthcare Triangle
Healthcare Triangle,
Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge
and expertise. We support healthcare organizations including hospitals and health systems, payers, and pharma/life sciences organizations
in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on. Healthcare
Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz and DataEz . HITRUST Risk-based,
2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare
Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and
competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital
transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical &
business performance optimization.
and Datono Mediacion SL
Proven AI Innovation and Customer Engagement
Meets Healthcare Expertise
The Assets which are headquartered in Madrid,
have built a sophisticated platform that seamlessly blends artificial intelligence with human expertise, currently serving banking and
insurance clients while piloting breakthrough healthcare applications. The company's technology stack includes advanced chatbot automation,
multilingual patient engagement tools, and real-time analytics, capabilities that become exponentially more powerful when integrated with
HCTI's clinical systems.
of the Assets' innovations include:
Statements and Safe Harbor Notice
All statements other than statements of historical
facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform
Act of 1995), and include, among others, statements regarding the consummation of the private placement, satisfaction of the customary
closing conditions of the private placement and the use of the proceeds therefrom. Such forward-looking statements include our expectations
and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate."
The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties, and assumptions,
including market and other conditions. Actual results could differ materially from current projections or implied results. Investors should
read the risk factors out lined in the company's annual report on form 10-K for the year ended December 31, 2024, on file with the Securities
Exchange Commission (the "SEC") and in previous filings, subsequent filings and future periodic reports filed with the SEC.
All the company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

Frequently Asked Questions

What is the planned acquisition by Healthcare Triangle?

Healthcare Triangle intends to acquire Teyame AI LLC and its associated assets.

How much revenue is expected from the acquisition in FY 2025?

The acquisition is anticipated to generate about $34 million in revenue for FY 2025.

When is the acquisition expected to close?

The parties aim to close the acquisition in the first quarter of 2026.

What type of technology will the acquisition enhance?

The acquisition will enhance AI-powered customer and patient engagement technologies.

What will integrate with HCTI's technology from the acquisition?

Advanced AI engagement platforms from the acquisition will integrate with HCTI's systems.

Last updated: Dec 10, 2025